ENZALUTAMIDE

ENZALUTAMIDE was reported 58866 times

ENZALUTAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MALIGNANT SPINAL CORD COMPRESSION 25 0.5952
1 ARRHYTHMIA INDUCED CARDIOMYOPATHY 29 0.5472
2 PROSTATIC SPECIFIC ANTIGEN INCREASED 4361 0.3162
3 HEREDITARY OPTIC ATROPHY 14 0.2000
4 PROSTATIC SPECIFIC ANTIGEN ABNORMAL 201 0.1936
5 HAEMATOLOGICAL NEOPLASM 13 0.1884
6 BRCA1 GENE MUTATION 15 0.1705
7 HORMONE-REFRACTORY PROSTATE CANCER 182 0.1532
8 BRCA2 GENE MUTATION 13 0.1368
9 PRODUCT SIZE ISSUE 615 0.1143
10 PROSTATE CANCER METASTATIC 318 0.0951
11 PROSTATIC SPECIFIC ANTIGEN DECREASED 35 0.0926
12 PROSTATE CANCER RECURRENT 56 0.0909
13 BLADDER TAMPONADE 17 0.0561
14 MALIGNANT NEOPLASM PROGRESSION 5499 0.0536
15 FOREIGN BODY IN RESPIRATORY TRACT 70 0.0534
16 METASTASES TO BLADDER 15 0.0526
17 HOT FLUSH 3932 0.0521
18 NEPHROSTOMY 16 0.0485
19 CANCER PAIN 120 0.0469
20 BLOOD TESTOSTERONE INCREASED 82 0.0381
21 RETROPERITONEAL LYMPHADENOPATHY 20 0.0380
22 BLOOD TESTOSTERONE ABNORMAL 42 0.0379
23 PROSTATIC PAIN 15 0.0368
24 FOREIGN BODY IN THROAT 115 0.0365
25 METASTASES TO PELVIS 23 0.0364
26 HYDROURETER 13 0.0342
27 METASTASES TO BONE 557 0.0339
28 ONCOLOGIC COMPLICATION 31 0.0321
29 OESOPHAGEAL ULCER HAEMORRHAGE 16 0.0314
30 BLADDER OBSTRUCTION 16 0.0311
31 TESTICULAR ATROPHY 27 0.0310
32 HAEMORRHAGE URINARY TRACT 74 0.0291
33 UNDERDOSE 2090 0.0286
34 BONE CANCER METASTATIC 15 0.0284
35 METASTASES TO SPINE 94 0.0279
36 NIPPLE PAIN 51 0.0250
37 RADIATION INJURY 26 0.0244
38 SPINAL CORD COMPRESSION 94 0.0241
39 SPINAL CORD NEOPLASM 21 0.0241
40 URINARY BLADDER HAEMORRHAGE 50 0.0237
41 PENILE SIZE REDUCED 22 0.0231
42 PRODUCT USE COMPLAINT 364 0.0231
43 INVESTIGATION 68 0.0217
44 URINARY TRACT OBSTRUCTION 51 0.0215
45 NOCTURIA 254 0.0209
46 BONE CANCER 87 0.0200
47 LAZINESS 34 0.0199
48 TESTICULAR DISORDER 20 0.0199
49 HEAD AND NECK CANCER 13 0.0192
50 BONE LESION 68 0.0188
51 MARASMUS 28 0.0184
52 METASTASES TO LYMPH NODES 122 0.0181
53 FOREIGN BODY ASPIRATION 13 0.0180
54 BLOOD URINE PRESENT 331 0.0174
55 BLADDER CATHETERISATION 16 0.0165
56 ABDOMINAL LYMPHADENOPATHY 14 0.0161
57 INCORRECT STORAGE OF DRUG 26 0.0150
58 BONE NEOPLASM 16 0.0148
59 FOREIGN BODY 59 0.0147
60 DECREASED APPETITE 3421 0.0147
61 RESTLESS LEGS SYNDROME 262 0.0144
62 INTENTIONAL UNDERDOSE 105 0.0144
63 HYPOGEUSIA 28 0.0143
64 COCCYDYNIA 21 0.0142
65 TESTICULAR PAIN 44 0.0139
66 DYSPHAGIA 1311 0.0138
67 BONE PAIN 799 0.0136
68 FATIGUE 10332 0.0133
69 URETERIC OBSTRUCTION 18 0.0132
70 URINE FLOW DECREASED 30 0.0125
71 PRESCRIBED UNDERDOSE 248 0.0124
72 MUSCLE ATROPHY 157 0.0124
73 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 15 0.0120
74 BREAST ENLARGEMENT 39 0.0119
75 PRODUCT AVAILABILITY ISSUE 271 0.0119
76 HYDRONEPHROSIS 88 0.0117
77 CALCULUS BLADDER 16 0.0117
78 PRODUCT SUPPLY ISSUE 83 0.0116
79 GASTROENTERITIS NOROVIRUS 15 0.0113
80 ASTHENIA 4207 0.0112
81 TREATMENT NONCOMPLIANCE 611 0.0112
82 METASTASIS 79 0.0111
83 TERMINAL STATE 73 0.0109
84 AGEUSIA 270 0.0108
85 TRANSITIONAL CELL CARCINOMA 14 0.0108
86 PROSTATE CANCER 867 0.0108
87 POLLAKIURIA 445 0.0107
88 CARDIOACTIVE DRUG LEVEL INCREASED 14 0.0106
89 DIPLEGIA 20 0.0101
90 FAECES HARD 39 0.0100
91 BLOOD TESTOSTERONE DECREASED 68 0.0099
92 BACK PAIN 2307 0.0099
93 PATHOLOGICAL FRACTURE 50 0.0098
94 PRODUCT PHYSICAL ISSUE 197 0.0098
95 BLADDER SPASM 18 0.0096
96 GROIN PAIN 84 0.0096
97 OSTEOSCLEROSIS 15 0.0095
98 OSTEONECROSIS OF JAW 234 0.0094
99 SEIZURE LIKE PHENOMENA 16 0.0094
100 HAEMATURIA 320 0.0093
101 MUSCULOSKELETAL CHEST PAIN 143 0.0092
102 MICTURITION DISORDER 32 0.0092
103 HYPERSOMNIA 264 0.0092
104 INCORRECT PRODUCT STORAGE 121 0.0092
105 INTERNATIONAL NORMALISED RATIO ABNORMAL 31 0.0090
106 PERFORMANCE STATUS DECREASED 42 0.0090
107 FAT TISSUE INCREASED 13 0.0090
108 ONYCHOLYSIS 14 0.0090
109 DEATH 7715 0.0089
110 MUSCULAR WEAKNESS 1012 0.0089
111 HOSPICE CARE 87 0.0088
112 MICTURITION URGENCY 100 0.0087
113 PERIPHERAL SWELLING 1340 0.0087
114 DIZZINESS POSTURAL 82 0.0084
115 REGURGITATION 29 0.0084
116 CONSTIPATION 1831 0.0084
117 CHOKING 163 0.0083
118 BLADDER NEOPLASM 14 0.0082
119 DYSGEUSIA 608 0.0082
120 BREAST SWELLING 22 0.0082
121 BALANCE DISORDER 707 0.0082
122 TASTE DISORDER 165 0.0081
123 CATHETER PLACEMENT 15 0.0081
124 INCONTINENCE 85 0.0080
125 DEMENTIA 223 0.0080
126 CERVICAL VERTEBRAL FRACTURE 27 0.0078
127 DYSURIA 288 0.0078
128 URINARY INCONTINENCE 230 0.0078
129 CHEST INJURY 16 0.0077
130 ADRENOCORTICAL INSUFFICIENCY ACUTE 15 0.0077
131 ERECTILE DYSFUNCTION 197 0.0077
132 PROSTATOMEGALY 30 0.0076
133 NIGHT SWEATS 246 0.0076
134 LARGE INTESTINAL OBSTRUCTION 17 0.0076
135 FAILURE TO THRIVE 39 0.0075
136 BOWEL MOVEMENT IRREGULARITY 57 0.0074
137 EXPOSED BONE IN JAW 16 0.0074
138 PHYSICAL DECONDITIONING 19 0.0074
139 METASTASES TO LUNG 85 0.0073
140 INITIAL INSOMNIA 75 0.0073
141 HYPERTENSIVE CRISIS 81 0.0073
142 INTERNATIONAL NORMALISED RATIO FLUCTUATION 15 0.0072
143 CACHEXIA 37 0.0072
144 URINARY RETENTION 239 0.0072
145 MUSCULOSKELETAL PAIN 375 0.0072
146 SLUGGISHNESS 73 0.0071
147 AMNESIA 465 0.0071
148 NEUROPATHY PERIPHERAL 677 0.0071
149 URINARY TRACT DISORDER 32 0.0071
150 THORACIC VERTEBRAL FRACTURE 21 0.0071
151 BREAST TENDERNESS 53 0.0070
152 SLOW SPEECH 17 0.0070
153 GYNAECOMASTIA 216 0.0070
154 URINE ODOUR ABNORMAL 41 0.0070
155 DECREASED INTEREST 41 0.0069
156 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 66 0.0069
157 SPINAL COMPRESSION FRACTURE 57 0.0069
158 IMMOBILE 30 0.0069
159 BRAIN FOG 106 0.0068
160 SPINAL COLUMN INJURY 15 0.0067
161 FEEDING DISORDER 136 0.0067
162 ADENOCARCINOMA 15 0.0067
163 INTERNATIONAL NORMALISED RATIO DECREASED 27 0.0067
164 EATING DISORDER 141 0.0066
165 METASTASES TO LIVER 116 0.0066
166 APATHY 96 0.0066
167 BREATH ODOUR 16 0.0066
168 SPINAL PAIN 76 0.0065
169 STENT PLACEMENT 52 0.0064
170 WEIGHT DECREASED 1795 0.0064
171 INTENTIONAL DOSE OMISSION 183 0.0064
172 SECOND PRIMARY MALIGNANCY 53 0.0064
173 DIZZINESS 3172 0.0064
174 POOR PERIPHERAL CIRCULATION 27 0.0063
175 BLADDER PAIN 20 0.0063
176 METASTATIC NEOPLASM 27 0.0063
177 COMPRESSION FRACTURE 33 0.0062
178 CARDIAC FAILURE CHRONIC 26 0.0061
179 INGUINAL HERNIA 37 0.0061
180 LISTLESS 20 0.0061
181 BLOOD CALCIUM DECREASED 68 0.0060
182 MEMORY IMPAIRMENT 829 0.0060
183 BEDRIDDEN 79 0.0060
184 DISCOURAGEMENT 14 0.0060
185 MONOPLEGIA 26 0.0060
186 URINARY TRACT INFECTION BACTERIAL 15 0.0059
187 ABDOMINAL DISCOMFORT 992 0.0059
188 LETHARGY 339 0.0059
189 INTERCEPTED PRODUCT STORAGE ERROR 21 0.0059
190 SKIN ODOUR ABNORMAL 23 0.0058
191 DRUG INTERACTION 925 0.0058
192 HUMERUS FRACTURE 28 0.0058
193 SUBDURAL HAEMATOMA 83 0.0058
194 CONFUSIONAL STATE 936 0.0058
195 ANAL INCONTINENCE 52 0.0058
196 MYALGIA 974 0.0057
197 HIP FRACTURE 183 0.0057
198 DRUG DOSE OMISSION 937 0.0057
199 CEREBRAL INFARCTION 138 0.0056
200 RETCHING 120 0.0056
201 BREAKTHROUGH PAIN 13 0.0056
202 FALL 1847 0.0055
203 MUSCLE STRAIN 48 0.0055
204 CEREBRAL ATROPHY 22 0.0055
205 MUSCLE FATIGUE 23 0.0054
206 PELVIC PAIN 98 0.0054
207 RIB FRACTURE 110 0.0053
208 NAIL DISCOLOURATION 21 0.0053
209 FULL BLOOD COUNT DECREASED 107 0.0053
210 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 376 0.0053
211 DECREASED ACTIVITY 57 0.0053
212 APPETITE DISORDER 35 0.0053
213 CYSTITIS 168 0.0053
214 PROSTATITIS 16 0.0053
215 DYSSTASIA 153 0.0052
216 MEDICATION RESIDUE PRESENT 25 0.0052
217 HEART VALVE INCOMPETENCE 15 0.0052
218 CLAVICLE FRACTURE 20 0.0052
219 ARTHRALGIA 2170 0.0052
220 CARDIAC FAILURE 418 0.0052
221 FLATULENCE 295 0.0052
222 OESOPHAGEAL DISORDER 20 0.0052
223 HYPERTONIC BLADDER 15 0.0052
224 INSOMNIA 1372 0.0051
225 GAIT INABILITY 172 0.0051
226 HYPERHIDROSIS 663 0.0051
227 SOMNOLENCE 1036 0.0051
228 MUSCULOSKELETAL DISCOMFORT 88 0.0051
229 NECK INJURY 15 0.0051
230 SPINAL STENOSIS 21 0.0051
231 PROSTATE CANCER STAGE IV 18 0.0051
232 NON-CARDIAC CHEST PAIN 16 0.0051
233 COGNITIVE DISORDER 236 0.0050
234 LIMB DISCOMFORT 156 0.0050
235 GENERAL PHYSICAL HEALTH DETERIORATION 582 0.0050
236 FORMICATION 35 0.0050
237 GINGIVITIS 27 0.0050
238 ONYCHOMADESIS 21 0.0050
239 PRODUCT DISTRIBUTION ISSUE 46 0.0050
240 NEOPLASM 57 0.0050
241 BLOOD PRESSURE INCREASED 756 0.0049
242 BLADDER DISORDER 49 0.0049
243 VENTRICULAR ARRHYTHMIA 18 0.0049
244 FUNCTIONAL GASTROINTESTINAL DISORDER 17 0.0049
245 LOSS OF LIBIDO 44 0.0049
246 BLOOD PRESSURE ABNORMAL 96 0.0048
247 DISORIENTATION 191 0.0048
248 DISEASE COMPLICATION 22 0.0048
249 VERTIGO 290 0.0048
250 PRODUCT STORAGE ERROR 415 0.0047
251 ANAEMIA 903 0.0047
252 BONE DISORDER 86 0.0047
253 HALLUCINATION 354 0.0047
254 FEMORAL NECK FRACTURE 24 0.0047
255 PRODUCT DOSE OMISSION 303 0.0046
256 TRANSIENT ISCHAEMIC ATTACK 156 0.0046
257 UPPER LIMB FRACTURE 92 0.0046
258 HYPOPHOSPHATAEMIA 34 0.0046
259 BREAST PAIN 49 0.0046
260 HEAD DISCOMFORT 81 0.0046
261 URINARY TRACT INFECTION 780 0.0046
262 RECTAL CANCER 14 0.0046
263 OESOPHAGEAL PAIN 18 0.0046
264 GAIT DISTURBANCE 867 0.0045
265 SEIZURE 521 0.0045
266 CARDIAC FAILURE ACUTE 30 0.0045
267 BLOOD PRESSURE FLUCTUATION 108 0.0045
268 TEMPERATURE INTOLERANCE 46 0.0045
269 MUSCLE DISORDER 36 0.0044
270 ULCER HAEMORRHAGE 30 0.0044
271 PRODUCT ODOUR ABNORMAL 46 0.0044
272 PAROSMIA 33 0.0044
273 DIARRHOEA 2813 0.0044
274 RASH GENERALISED 112 0.0043
275 AORTIC STENOSIS 15 0.0043
276 GASTROINTESTINAL MOTILITY DISORDER 23 0.0043
277 METASTASES TO CENTRAL NERVOUS SYSTEM 55 0.0043
278 HYPOPHAGIA 109 0.0043
279 FAECES SOFT 31 0.0043
280 HYPOAESTHESIA 637 0.0043
281 PNEUMONIA ASPIRATION 106 0.0042
282 OEDEMA PERIPHERAL 517 0.0042
283 UROSEPSIS 39 0.0042
284 HYPOCALCAEMIA 80 0.0042
285 ACUTE CORONARY SYNDROME 35 0.0042
286 SLEEP DISORDER 296 0.0042
287 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 141 0.0042
288 PAIN IN EXTREMITY 1230 0.0042
289 APPARENT DEATH 15 0.0042
290 GINGIVAL DISORDER 16 0.0042
291 FLANK PAIN 39 0.0042
292 NAUSEA 3270 0.0041
293 DEHYDRATION 551 0.0041
294 AORTIC DISSECTION 17 0.0041
295 SALIVARY HYPERSECRETION 41 0.0041
296 FEELING OF DESPAIR 19 0.0041
297 ABNORMAL DREAMS 112 0.0041
298 CARDIAC DYSFUNCTION 15 0.0040
299 GOUT 72 0.0040
300 RHINORRHOEA 259 0.0040
301 HAEMOGLOBIN DECREASED 411 0.0040
302 EXERCISE TOLERANCE DECREASED 23 0.0040
303 HEPATIC FUNCTION ABNORMAL 149 0.0040
304 NIGHTMARE 138 0.0040
305 CHROMATURIA 90 0.0040
306 EMBOLIC STROKE 14 0.0040
307 WALKING AID USER 26 0.0039
308 HYPOKINESIA 57 0.0039
309 ASPIRATION 43 0.0039
310 CEREBROVASCULAR ACCIDENT 665 0.0039
311 FEELING COLD 109 0.0039
312 HYPOTONIA 39 0.0039
313 BLOOD CHOLESTEROL ABNORMAL 18 0.0039
314 OEDEMA 211 0.0039
315 GENERALISED OEDEMA 48 0.0039
316 POOR QUALITY DRUG ADMINISTERED 25 0.0039
317 ATRIAL FIBRILLATION 376 0.0039
318 EPISTAXIS 287 0.0038
319 NECK PAIN 214 0.0038
320 BRADYPHRENIA 25 0.0038
321 SCIATICA 61 0.0038
322 FLUID RETENTION 194 0.0038
323 LOSS OF CONSCIOUSNESS 488 0.0038
324 SKIN ABRASION 18 0.0038
325 FLUID INTAKE REDUCED 19 0.0038
326 EPILEPSY 116 0.0038
327 SINUS DISORDER 75 0.0038
328 INTERSTITIAL LUNG DISEASE 183 0.0038
329 FEELING OF BODY TEMPERATURE CHANGE 22 0.0037
330 FRACTURE 71 0.0037
331 LUMBAR VERTEBRAL FRACTURE 17 0.0037
332 CHOLECYSTITIS ACUTE 21 0.0037
333 BUNDLE BRANCH BLOCK RIGHT 17 0.0037
334 POOR QUALITY PRODUCT ADMINISTERED 39 0.0037
335 HALLUCINATION, VISUAL 78 0.0037
336 RENAL PAIN 39 0.0037
337 HAEMORRHAGE SUBCUTANEOUS 13 0.0037
338 VISION BLURRED 503 0.0037
339 ISCHAEMIC STROKE 65 0.0036
340 HEAD INJURY 115 0.0036
341 HYPOACUSIS 156 0.0036
342 MALAISE 1588 0.0036
343 FACIAL BONES FRACTURE 13 0.0036
344 THROAT IRRITATION 161 0.0036
345 ELECTROCARDIOGRAM QT PROLONGED 129 0.0036
346 PROCTALGIA 23 0.0036
347 HAEMOGLOBIN ABNORMAL 23 0.0036
348 PIGMENTATION DISORDER 22 0.0036
349 FEELING ABNORMAL 852 0.0036
350 DUODENAL ULCER 25 0.0035
351 PARAESTHESIA 556 0.0035
352 KIDNEY INFECTION 69 0.0035
353 BACK DISORDER 57 0.0035
354 LYMPHADENOPATHY 124 0.0035
355 BRAIN NEOPLASM 32 0.0035
356 JAW DISORDER 19 0.0035
357 HYPERTENSION 734 0.0035
358 TOOTH FRACTURE 38 0.0034
359 URINE OUTPUT DECREASED 30 0.0034
360 NAIL DISORDER 30 0.0034
361 TOOTHACHE 62 0.0034
362 AORTIC ANEURYSM 26 0.0034
363 EAR DISCOMFORT 35 0.0034
364 BACK INJURY 37 0.0034
365 MUSCULOSKELETAL STIFFNESS 298 0.0034
366 GENERAL PHYSICAL CONDITION ABNORMAL 23 0.0034
367 PRODUCT DOSE OMISSION IN ERROR 96 0.0034
368 CARDIAC FAILURE CONGESTIVE 271 0.0034
369 MIDDLE INSOMNIA 63 0.0034
370 JOINT SWELLING 406 0.0034
371 MASS 47 0.0034
372 MUSCLE TWITCHING 77 0.0033
373 BLOOD POTASSIUM INCREASED 54 0.0033
374 INTERNAL HAEMORRHAGE 38 0.0033
375 DECUBITUS ULCER 27 0.0033
376 URINE ABNORMALITY 15 0.0033
377 ESCHERICHIA URINARY TRACT INFECTION 14 0.0033
378 BLOOD SODIUM DECREASED 62 0.0033
379 MOBILITY DECREASED 234 0.0033
380 SNEEZING 73 0.0033
381 EMBOLISM 27 0.0032
382 NERVE COMPRESSION 30 0.0032
383 INCREASED APPETITE 62 0.0032
384 JOINT STIFFNESS 85 0.0032
385 GASTRIC HAEMORRHAGE 37 0.0032
386 ERUCTATION 62 0.0032
387 DISEASE PROGRESSION 378 0.0032
388 SPINAL FRACTURE 64 0.0032
389 BLOOD GLUCOSE FLUCTUATION 35 0.0032
390 HOSPITALISATION 490 0.0032
391 CARDIAC PACEMAKER INSERTION 19 0.0032
392 RED BLOOD CELL COUNT DECREASED 91 0.0032
393 RENAL DISORDER 148 0.0032
394 DISTURBANCE IN ATTENTION 171 0.0032
395 ORTHOSTATIC HYPOTENSION 55 0.0032
396 ABASIA 78 0.0032
397 PERIPHERAL COLDNESS 43 0.0031
398 BLOOD IRON DECREASED 37 0.0031
399 LACRIMATION INCREASED 94 0.0031
400 DYSPNOEA EXERTIONAL 117 0.0031
401 DRUG INTOLERANCE 300 0.0031
402 DYSPEPSIA 304 0.0031
403 DRUG INEFFECTIVE 4067 0.0031
404 LOWER LIMB FRACTURE 59 0.0031
405 HYPERCHLORHYDRIA 18 0.0031
406 POLYURIA 25 0.0030
407 ENERGY INCREASED 18 0.0030
408 MOTOR DYSFUNCTION 31 0.0030
409 LOCAL SWELLING 53 0.0030
410 LYMPHOEDEMA 21 0.0030
411 MENTAL STATUS CHANGES 84 0.0030
412 GASTRITIS EROSIVE 14 0.0030
413 GENERALISED ERYTHEMA 17 0.0030
414 OSTEOMYELITIS 54 0.0030
415 BLOOD ALKALINE PHOSPHATASE INCREASED 74 0.0030
416 PLATELET COUNT DECREASED 317 0.0030
417 CEREBRAL DISORDER 22 0.0030
418 CARDIAC DISORDER 278 0.0030
419 BLOOD CALCIUM INCREASED 26 0.0030
420 SPINAL COLUMN STENOSIS 14 0.0030
421 TRANSFUSION 31 0.0030
422 COLON CANCER 44 0.0029
423 ARTHRITIS 232 0.0029
424 DRUG LEVEL DECREASED 30 0.0029
425 DEAFNESS 77 0.0029
426 POOR QUALITY SLEEP 63 0.0029
427 DIPLOPIA 76 0.0029
428 FAECALOMA 16 0.0029
429 PRODUCT TEMPERATURE EXCURSION ISSUE 15 0.0029
430 HYPOAESTHESIA ORAL 44 0.0029
431 FAECAL INCONTINENCE 14 0.0029
432 UPPER-AIRWAY COUGH SYNDROME 24 0.0029
433 DEAFNESS UNILATERAL 16 0.0029
434 MYOCARDIAL ISCHAEMIA 33 0.0029
435 SYNCOPE 290 0.0029
436 LOCALISED INFECTION 70 0.0029
437 ABDOMINAL PAIN UPPER 594 0.0029
438 EMPHYSEMA 29 0.0029
439 ARTERIOSCLEROSIS 27 0.0029
440 CATARACT OPERATION 17 0.0029
441 HAEMATOCHEZIA 158 0.0029
442 FRUSTRATION TOLERANCE DECREASED 23 0.0028
443 CORONARY ARTERY OCCLUSION 39 0.0028
444 PAIN 1746 0.0028
445 CONCUSSION 22 0.0028
446 POLYNEUROPATHY 34 0.0028
447 HYPERCALCAEMIA 35 0.0028
448 HYPERVOLAEMIA 14 0.0028
449 QUALITY OF LIFE DECREASED 38 0.0028
450 BLOOD POTASSIUM DECREASED 85 0.0028
451 ANORECTAL DISCOMFORT 15 0.0028
452 HYPOMAGNESAEMIA 39 0.0028
453 HAEMATEMESIS 71 0.0028
454 ADVERSE EVENT 258 0.0028
455 NEUROLOGICAL SYMPTOM 16 0.0028
456 PERSONALITY CHANGE 26 0.0028
457 ABDOMINAL DISTENSION 292 0.0028
458 FEELING JITTERY 53 0.0028
459 GASTRITIS 73 0.0028
460 MALNUTRITION 31 0.0028
461 DISSEMINATED INTRAVASCULAR COAGULATION 39 0.0028
462 MENTAL IMPAIRMENT 67 0.0028
463 LIMB INJURY 75 0.0028
464 PRESYNCOPE 67 0.0028
465 TOOTH EXTRACTION 34 0.0027
466 PULMONARY CONGESTION 36 0.0027
467 PLEURAL EFFUSION 166 0.0027
468 PROSTATIC DISORDER 15 0.0027
469 BRADYKINESIA 16 0.0027
470 MOVEMENT DISORDER 87 0.0027
471 LOWER GASTROINTESTINAL HAEMORRHAGE 20 0.0027
472 INTERVERTEBRAL DISC DEGENERATION 25 0.0027
473 TOOTH DISORDER 60 0.0027
474 VOMITING 1264 0.0027
475 GASTRIC ULCER 51 0.0027
476 ACCIDENT 32 0.0027
477 DYSPNOEA 1515 0.0027
478 FAECES DISCOLOURED 58 0.0027
479 HORMONE LEVEL ABNORMAL 13 0.0027
480 HEADACHE 1670 0.0027
481 VISUAL IMPAIRMENT 330 0.0027
482 OESOPHAGITIS 29 0.0027
483 DELIRIUM 92 0.0026
484 JOINT DISLOCATION 28 0.0026
485 HYPOKALAEMIA 122 0.0026
486 THROMBOCYTOPENIA 295 0.0026
487 ATRIAL FLUTTER 21 0.0026
488 CARDIAC FLUTTER 17 0.0026
489 CEREBRAL HAEMORRHAGE 94 0.0026
490 BLOOD DISORDER 21 0.0026
491 PAIN IN JAW 74 0.0026
492 ANEURYSM 13 0.0026
493 COLD SWEAT 46 0.0026
494 SKIN ATROPHY 15 0.0026
495 MOOD SWINGS 83 0.0026
496 BLOOD PRESSURE DECREASED 173 0.0026
497 HAIR GROWTH ABNORMAL 18 0.0026
498 DYSPHONIA 152 0.0026
499 GASTRIC DISORDER 89 0.0026
500 SEPSIS 289 0.0026
501 MUSCLE SPASMS 475 0.0026
502 CORONARY ARTERY STENOSIS 13 0.0026
503 THINKING ABNORMAL 48 0.0026
504 ASPHYXIA 21 0.0026
505 BLOOD COUNT ABNORMAL 39 0.0026
506 CORONARY ARTERIAL STENT INSERTION 13 0.0026
507 HAEMORRHAGIC STROKE 20 0.0026
508 SUDDEN DEATH 27 0.0025
509 PULMONARY MASS 38 0.0025
510 FEELING HOT 156 0.0025
511 VITREOUS FLOATERS 25 0.0025
512 CHEST PAIN 470 0.0025
513 RECTAL HAEMORRHAGE 109 0.0025
514 ARRHYTHMIA 120 0.0025
515 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 121 0.0025
516 PRODUCT TASTE ABNORMAL 34 0.0025
517 TROPONIN INCREASED 19 0.0025
518 MOOD ALTERED 68 0.0025
519 MYELODYSPLASTIC SYNDROME 36 0.0025
520 DEPRESSED MOOD 131 0.0025
521 ACUTE MYOCARDIAL INFARCTION 73 0.0025
522 LIVER FUNCTION TEST INCREASED 53 0.0025
523 THERAPY INTERRUPTED 176 0.0025
524 SPEECH DISORDER 129 0.0025
525 SHOCK HAEMORRHAGIC 20 0.0025
526 RASH PRURITIC 133 0.0025
527 DEPRESSED LEVEL OF CONSCIOUSNESS 97 0.0024
528 CARDIAC VALVE DISEASE 14 0.0024
529 CARDIAC OPERATION 21 0.0024
530 NEPHROLITHIASIS 112 0.0024
531 PELVIC FRACTURE 19 0.0024
532 DEPRESSION 555 0.0024
533 HYPERAESTHESIA 20 0.0024
534 HEART RATE IRREGULAR 55 0.0024
535 PRODUCTIVE COUGH 116 0.0024
536 HAEMATOTOXICITY 23 0.0024
537 BLOOD TEST ABNORMAL 34 0.0024
538 WRIST FRACTURE 29 0.0024
539 HERPES ZOSTER 139 0.0024
540 DIVERTICULITIS 67 0.0024
541 OLIGURIA 15 0.0024
542 ILEUS 30 0.0024
543 DEVICE RELATED INFECTION 37 0.0024
544 LYMPHOMA 37 0.0024
545 NASAL DRYNESS 15 0.0024
546 GLAUCOMA 46 0.0024
547 NEURALGIA 58 0.0024
548 PULMONARY THROMBOSIS 26 0.0024
549 RASH MACULO-PAPULAR 53 0.0024
550 TREMOR 395 0.0024
551 RESTLESSNESS 87 0.0024
552 MYOCARDIAL INFARCTION 414 0.0024
553 FACIAL PAIN 21 0.0024
554 APHASIA 71 0.0023
555 FACIAL PARALYSIS 20 0.0023
556 DRUG PRESCRIBING ERROR 45 0.0023
557 DYSKINESIA 95 0.0023
558 SEASONAL ALLERGY 33 0.0023
559 HEART RATE ABNORMAL 13 0.0023
560 PANCYTOPENIA 130 0.0023
561 GANGRENE 14 0.0023
562 ACTIVITIES OF DAILY LIVING IMPAIRED 46 0.0023
563 SPINAL DISORDER 22 0.0023
564 INCOHERENT 15 0.0023
565 DRY MOUTH 188 0.0023
566 DROOLING 16 0.0023
567 DRUG ERUPTION 41 0.0023
568 LABORATORY TEST ABNORMAL 68 0.0023
569 PSYCHIATRIC SYMPTOM 17 0.0023
570 SWELLING 215 0.0023
571 RENAL IMPAIRMENT 193 0.0023
572 WEIGHT INCREASED 514 0.0023
573 CLOSTRIDIUM DIFFICILE INFECTION 50 0.0023
574 PNEUMONIA 740 0.0023
575 TINNITUS 105 0.0023
576 THROMBOSIS 183 0.0023
577 BLOOD GLUCOSE ABNORMAL 42 0.0023
578 ACCIDENTAL OVERDOSE 83 0.0023
579 ACUTE HEPATIC FAILURE 31 0.0023
580 BURNING SENSATION 159 0.0023
581 INTESTINAL OBSTRUCTION 85 0.0023
582 CORONARY ARTERY DISEASE 68 0.0022
583 EMOTIONAL DISORDER 69 0.0022
584 MUSCLE TIGHTNESS 36 0.0022
585 LIP SWELLING 74 0.0022
586 FREQUENT BOWEL MOVEMENTS 60 0.0022
587 LEUKOPENIA 111 0.0022
588 CHILLS 260 0.0022
589 DYSARTHRIA 83 0.0022
590 NEOPLASM MALIGNANT 147 0.0022
591 TOOTH INFECTION 29 0.0022
592 GASTROOESOPHAGEAL REFLUX DISEASE 177 0.0022
593 GINGIVAL BLEEDING 30 0.0022
594 ABNORMAL FAECES 18 0.0022
595 BLINDNESS TRANSIENT 16 0.0022
596 HYPONATRAEMIA 122 0.0022
597 FLUSHING 220 0.0022
598 CARDIOGENIC SHOCK 31 0.0022
599 NERVE INJURY 24 0.0022
600 MUSCULOSKELETAL DISORDER 41 0.0022
601 FEELING DRUNK 16 0.0022
602 EXTRASYSTOLES 15 0.0021
603 NASOPHARYNGITIS 395 0.0021
604 GINGIVAL PAIN 17 0.0021
605 CYTOPENIA 26 0.0021
606 VENTRICULAR EXTRASYSTOLES 22 0.0021
607 SENSORY DISTURBANCE 34 0.0021
608 INABILITY TO AFFORD MEDICATION 21 0.0021
609 NASAL CONGESTION 124 0.0021
610 ASPARTATE AMINOTRANSFERASE INCREASED 112 0.0021
611 BLOOD PRESSURE SYSTOLIC INCREASED 41 0.0021
612 PULMONARY OEDEMA 94 0.0021
613 LIVER DISORDER 93 0.0021
614 ATRIOVENTRICULAR BLOCK COMPLETE 14 0.0021
615 DIABETES MELLITUS INADEQUATE CONTROL 37 0.0021
616 MULTIPLE ORGAN DYSFUNCTION SYNDROME 59 0.0021
617 DENTAL CARIES 23 0.0021
618 PYELONEPHRITIS 18 0.0021
619 CLOSTRIDIUM DIFFICILE COLITIS 22 0.0021
620 PNEUMONIA BACTERIAL 19 0.0021
621 ATRIOVENTRICULAR BLOCK 16 0.0021
622 JOINT INJURY 44 0.0021
623 EAR PAIN 40 0.0021
624 HYPERKALAEMIA 72 0.0021
625 HEART RATE DECREASED 72 0.0020
626 HEMIPLEGIA 17 0.0020
627 NEOPLASM PROGRESSION 71 0.0020
628 PRURITUS GENERALISED 44 0.0020
629 ANXIETY 579 0.0020
630 SPINAL OPERATION 25 0.0020
631 SENSATION OF FOREIGN BODY 17 0.0020
632 HAEMATOCRIT DECREASED 40 0.0020
633 RENAL CYST 16 0.0020
634 MACULAR DEGENERATION 24 0.0020
635 WEIGHT FLUCTUATION 21 0.0020
636 VENTRICULAR TACHYCARDIA 33 0.0020
637 SECRETION DISCHARGE 25 0.0020
638 LUNG INFECTION 31 0.0020
639 DRUG RESISTANCE 51 0.0020
640 DRUG-INDUCED LIVER INJURY 62 0.0020
641 LUNG NEOPLASM MALIGNANT 81 0.0020
642 BLOOD MAGNESIUM DECREASED 17 0.0020
643 CORONAVIRUS INFECTION 13 0.0020
644 HERNIA 38 0.0020
645 TOOTH ABSCESS 20 0.0020
646 HIP ARTHROPLASTY 30 0.0020
647 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
648 PARALYSIS 28 0.0020
649 ALANINE AMINOTRANSFERASE INCREASED 120 0.0020
650 RASH 851 0.0020
651 GASTROENTERITIS VIRAL 35 0.0019
652 TONGUE DISORDER 14 0.0019
653 NERVOUSNESS 101 0.0019
654 HEPATOTOXICITY 43 0.0019
655 SINUS CONGESTION 26 0.0019
656 DEVICE OCCLUSION 27 0.0019
657 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 100 0.0019
658 FEMUR FRACTURE 59 0.0019
659 PERICARDIAL EFFUSION 44 0.0019
660 ABDOMINAL PAIN LOWER 48 0.0019
661 CARDIOMYOPATHY 28 0.0019
662 PRODUCT PACKAGING ISSUE 18 0.0019
663 ARTHROPOD BITE 14 0.0019
664 IMPAIRED QUALITY OF LIFE 27 0.0019
665 BONE MARROW FAILURE 38 0.0019
666 DRY THROAT 19 0.0019
667 HUNGER 26 0.0019
668 SENSORY LOSS 15 0.0019
669 SINUS BRADYCARDIA 18 0.0019
670 JAUNDICE 50 0.0019
671 CATARACT 109 0.0018
672 SWELLING FACE 119 0.0018
673 CELLULITIS 92 0.0018
674 EYE DISORDER 60 0.0018
675 ULCER 29 0.0018
676 ERYTHEMA MULTIFORME 17 0.0018
677 SPINAL OSTEOARTHRITIS 16 0.0018
678 UNRESPONSIVE TO STIMULI 47 0.0018
679 GASTROINTESTINAL PAIN 20 0.0018
680 BLINDNESS 74 0.0018
681 ANGINA PECTORIS 52 0.0018
682 ALOPECIA 356 0.0018
683 INFLUENZA 202 0.0018
684 VENTRICULAR FIBRILLATION 20 0.0018
685 SPLENOMEGALY 21 0.0018
686 APHONIA 25 0.0018
687 HEPATIC FAILURE 54 0.0018
688 DRY SKIN 239 0.0018
689 HYPOTENSION 359 0.0018
690 INJECTION SITE MASS 66 0.0018
691 OSTEOPOROSIS 73 0.0018
692 OROPHARYNGEAL DISCOMFORT 16 0.0018
693 ROAD TRAFFIC ACCIDENT 74 0.0018
694 OROPHARYNGEAL PAIN 163 0.0018
695 IMPAIRED DRIVING ABILITY 20 0.0018
696 ENCEPHALOPATHY 43 0.0017
697 INFECTION 251 0.0017
698 CARDIAC MURMUR 15 0.0017
699 ADRENAL INSUFFICIENCY 21 0.0017
700 COUGH 485 0.0017
701 TENDERNESS 18 0.0017
702 INFLUENZA LIKE ILLNESS 142 0.0017
703 NO THERAPEUTIC RESPONSE 21 0.0017
704 ACUTE RESPIRATORY FAILURE 33 0.0017
705 DIARRHOEA HAEMORRHAGIC 16 0.0017
706 ALTERED STATE OF CONSCIOUSNESS 37 0.0017
707 CARDIOMEGALY 21 0.0017
708 HEART RATE INCREASED 169 0.0017
709 INSURANCE ISSUE 26 0.0017
710 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 15 0.0017
711 COVID-19 PNEUMONIA 20 0.0017
712 INTERVERTEBRAL DISC PROTRUSION 37 0.0017
713 RESPIRATORY TRACT INFECTION 44 0.0017
714 UPPER RESPIRATORY TRACT INFECTION 78 0.0017
715 BACTERAEMIA 20 0.0017
716 HYPOALBUMINAEMIA 13 0.0017
717 SUBARACHNOID HAEMORRHAGE 17 0.0017
718 DERMATITIS CONTACT 19 0.0017
719 CARDIOVASCULAR DISORDER 42 0.0017
720 SKIN DISCOLOURATION 76 0.0017
721 TREATMENT FAILURE 137 0.0017
722 COORDINATION ABNORMAL 23 0.0016
723 INTERNATIONAL NORMALISED RATIO INCREASED 47 0.0016
724 ACUTE KIDNEY INJURY 252 0.0016
725 BLOOD CHOLESTEROL INCREASED 76 0.0016
726 GASTROINTESTINAL DISORDER 146 0.0016
727 SMALL INTESTINAL OBSTRUCTION 20 0.0016
728 SLEEP APNOEA SYNDROME 31 0.0016
729 THIRST 29 0.0016
730 HIATUS HERNIA 21 0.0016
731 DIABETES MELLITUS 123 0.0016
732 ORAL PAIN 36 0.0016
733 NERVOUS SYSTEM DISORDER 50 0.0016
734 CHEST DISCOMFORT 164 0.0016
735 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 287 0.0016
736 TUMOUR LYSIS SYNDROME 14 0.0016
737 MITRAL VALVE INCOMPETENCE 18 0.0016
738 RENAL FAILURE 211 0.0016
739 BLOOD GLUCOSE DECREASED 76 0.0016
740 HAEMORRHAGE 165 0.0016
741 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 27 0.0016
742 SWOLLEN TONGUE 49 0.0016
743 PULMONARY EMBOLISM 149 0.0016
744 SUPRAVENTRICULAR TACHYCARDIA 15 0.0016
745 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
746 LIP DRY 14 0.0015
747 MENTAL DISORDER 67 0.0015
748 CARDIAC ARREST 127 0.0015
749 HAEMORRHOIDS 30 0.0015
750 INCORRECT DOSE ADMINISTERED 350 0.0015
751 ABDOMINAL PAIN 354 0.0015
752 ANOSMIA 22 0.0015
753 COMPLICATION ASSOCIATED WITH DEVICE 22 0.0015
754 PANCREATITIS ACUTE 34 0.0015
755 PRURITUS 581 0.0015
756 CHOLESTASIS 29 0.0015
757 SKIN ULCER 39 0.0015
758 PALLOR 41 0.0015
759 CONTUSION 144 0.0015
760 PNEUMOCYSTIS JIROVECII PNEUMONIA 15 0.0015
761 DISCOMFORT 91 0.0015
762 HEPATIC CIRRHOSIS 28 0.0015
763 STEVENS-JOHNSON SYNDROME 33 0.0015
764 SKIN LACERATION 16 0.0015
765 PRODUCT DISPENSING ERROR 32 0.0015
766 BONE LOSS 22 0.0015
767 HYPERGLYCAEMIA 53 0.0015
768 INTENTIONAL PRODUCT MISUSE 127 0.0014
769 EYE DISCHARGE 15 0.0014
770 NEUTROPENIA 196 0.0014
771 TRANSAMINASES INCREASED 32 0.0014
772 CONDITION AGGRAVATED 437 0.0014
773 PYREXIA 495 0.0014
774 PHARYNGEAL OEDEMA 22 0.0014
775 CHOLECYSTITIS 17 0.0014
776 BRAIN OEDEMA 18 0.0014
777 SEPTIC SHOCK 62 0.0014
778 MALIGNANT MELANOMA 19 0.0014
779 LIGAMENT SPRAIN 14 0.0014
780 INFLAMMATION 73 0.0014
781 THERAPY PARTIAL RESPONDER 22 0.0014
782 BASAL CELL CARCINOMA 22 0.0014
783 LIVER FUNCTION TEST ABNORMAL 41 0.0014
784 CIRCULATORY COLLAPSE 24 0.0014
785 MELAENA 31 0.0014
786 IRON DEFICIENCY ANAEMIA 13 0.0014
787 HAEMORRHAGE INTRACRANIAL 21 0.0014
788 RESPIRATORY DISORDER 42 0.0014
789 WHITE BLOOD CELL COUNT DECREASED 152 0.0014
790 BACTERIAL INFECTION 26 0.0014
791 INTENTIONAL PRODUCT USE ISSUE 122 0.0014
792 LUNG DISORDER 68 0.0014
793 DERMATITIS 29 0.0014
794 CENTRAL NERVOUS SYSTEM LESION 19 0.0014
795 BLOOD GLUCOSE INCREASED 260 0.0014
796 GASTROINTESTINAL HAEMORRHAGE 115 0.0014
797 GASTROENTERITIS 20 0.0014
798 THROAT TIGHTNESS 37 0.0014
799 HAEMOPTYSIS 38 0.0014
800 ASCITES 40 0.0014
801 BLOOD TRIGLYCERIDES INCREASED 24 0.0014
802 HEMIPARESIS 23 0.0014
803 HAEMATOMA 35 0.0013
804 SKIN DISORDER 45 0.0013
805 BLOOD CREATININE INCREASED 88 0.0013
806 RESPIRATORY FAILURE 98 0.0013
807 STAPHYLOCOCCAL INFECTION 44 0.0013
808 INTRAOCULAR PRESSURE INCREASED 17 0.0013
809 ILLNESS 137 0.0013
810 EYE INFECTION 15 0.0013
811 ADVERSE DRUG REACTION 119 0.0013
812 PNEUMONITIS 36 0.0013
813 PANIC ATTACK 48 0.0013
814 IRRITABILITY 79 0.0013
815 EJECTION FRACTION DECREASED 20 0.0013
816 EYELID PTOSIS 13 0.0013
817 ARTHROPATHY 71 0.0013
818 DERMATITIS ALLERGIC 16 0.0013
819 PHOTOSENSITIVITY REACTION 21 0.0013
820 LEUKOCYTOSIS 23 0.0013
821 GENERALISED TONIC-CLONIC SEIZURE 21 0.0013
822 HEPATIC ENZYME INCREASED 86 0.0013
823 PULMONARY FIBROSIS 24 0.0012
824 OSTEOARTHRITIS 53 0.0012
825 DRUG DISPENSING ERROR 19 0.0012
826 BURSITIS 15 0.0012
827 THYROID DISORDER 19 0.0012
828 DEEP VEIN THROMBOSIS 80 0.0012
829 UNEVALUABLE EVENT 93 0.0012
830 FULL BLOOD COUNT ABNORMAL 13 0.0012
831 BLISTER 69 0.0012
832 SURGERY 72 0.0012
833 DELUSION 19 0.0012
834 BLOOD BILIRUBIN INCREASED 33 0.0012
835 MYOCARDITIS 14 0.0012
836 HYPOTHYROIDISM 39 0.0012
837 INTERCEPTED PRODUCT PREPARATION ERROR 15 0.0012
838 OFF LABEL USE 1059 0.0012
839 ELECTROLYTE IMBALANCE 14 0.0012
840 EAR INFECTION 32 0.0012
841 NEUTROPHIL COUNT DECREASED 49 0.0012
842 PNEUMOTHORAX 19 0.0012
843 SKIN EXFOLIATION 101 0.0012
844 THERAPY CESSATION 61 0.0012
845 COLITIS 45 0.0012
846 THERAPEUTIC RESPONSE UNEXPECTED 53 0.0012
847 ATAXIA 14 0.0012
848 GALLBLADDER DISORDER 21 0.0012
849 BRONCHITIS 87 0.0012
850 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 238 0.0012
851 VIRAL INFECTION 39 0.0012
852 FOOT FRACTURE 22 0.0012
853 TOOTH LOSS 24 0.0012
854 WRONG TECHNIQUE IN DRUG USAGE PROCESS 42 0.0012
855 ORAL DISCOMFORT 16 0.0012
856 NODULE 15 0.0011
857 CARDIO-RESPIRATORY ARREST 48 0.0011
858 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
859 EYE HAEMORRHAGE 15 0.0011
860 RASH MACULAR 39 0.0011
861 DRY EYE 55 0.0011
862 FEBRILE NEUTROPENIA 73 0.0011
863 ANKLE FRACTURE 17 0.0011
864 CHOLELITHIASIS 36 0.0011
865 BRADYCARDIA 58 0.0011
866 RESPIRATORY DISTRESS 30 0.0011
867 SINUSITIS 111 0.0011
868 HYPERSENSITIVITY 201 0.0011
869 BLOOD LACTATE DEHYDROGENASE INCREASED 17 0.0011
870 HYPOGLYCAEMIA 52 0.0011
871 SKIN CANCER 23 0.0011
872 IMPAIRED HEALING 35 0.0011
873 CANDIDA INFECTION 18 0.0011
874 GASTRIC CANCER 27 0.0011
875 ABSCESS 17 0.0011
876 ORAL CANDIDIASIS 14 0.0011
877 SARS-COV-2 TEST POSITIVE 14 0.0011
878 CYST 13 0.0010
879 PANCREATIC CARCINOMA 30 0.0010
880 ILL-DEFINED DISORDER 63 0.0010
881 TACHYCARDIA 92 0.0010
882 ABNORMAL BEHAVIOUR 41 0.0010
883 TENDONITIS 16 0.0010
884 BLOOD UREA INCREASED 17 0.0010
885 INFUSION RELATED REACTION 67 0.0010
886 COVID-19 176 0.0010
887 BLINDNESS UNILATERAL 14 0.0010
888 GLYCOSYLATED HAEMOGLOBIN INCREASED 25 0.0010
889 ADVERSE REACTION 13 0.0010
890 THERAPY NON-RESPONDER 44 0.0010
891 ERYTHEMA 200 0.0010
892 HAIR TEXTURE ABNORMAL 13 0.0010
893 SYRINGE ISSUE 17 0.0010
894 HYPOXIA 34 0.0010
895 DRUG EFFECT INCOMPLETE 35 0.0010
896 FLUID OVERLOAD 14 0.0010
897 FACE OEDEMA 16 0.0009
898 GAMMA-GLUTAMYLTRANSFERASE INCREASED 21 0.0009
899 VISUAL ACUITY REDUCED 31 0.0009
900 BODY TEMPERATURE INCREASED 19 0.0009
901 PALPITATIONS 109 0.0009
902 PRODUCT PRESCRIBING ERROR 22 0.0009
903 OSTEOPENIA 14 0.0009
904 RASH ERYTHEMATOUS 44 0.0009
905 PRODUCT USE IN UNAPPROVED INDICATION 228 0.0009
906 BLADDER CANCER 54 0.0009
907 CONVULSION 52 0.0009
908 PHOTOPHOBIA 17 0.0009
909 COAGULOPATHY 15 0.0009
910 HEPATITIS 23 0.0009
911 PRODUCT ADMINISTRATION ERROR 18 0.0009
912 STOMATITIS 54 0.0009
913 MYELOSUPPRESSION 32 0.0009
914 POST PROCEDURAL COMPLICATION 17 0.0009
915 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 15 0.0009
916 EXPIRED PRODUCT ADMINISTERED 29 0.0009
917 HEPATIC STEATOSIS 16 0.0009
918 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 20 0.0009
919 ANGER 29 0.0009
920 PSYCHOTIC DISORDER 25 0.0008
921 AGITATION 62 0.0008
922 FUNGAL INFECTION 28 0.0008
923 OXYGEN SATURATION DECREASED 47 0.0008
924 WHITE BLOOD CELL COUNT INCREASED 32 0.0008
925 EYE PRURITUS 28 0.0008
926 FEAR 22 0.0008
927 URTICARIA 136 0.0008
928 RASH PAPULAR 18 0.0008
929 SKIN LESION 22 0.0008
930 OCULAR HYPERAEMIA 38 0.0008
931 ANGIOEDEMA 35 0.0008
932 PRODUCT PRESCRIBING ISSUE 17 0.0008
933 PANCREATITIS 41 0.0008
934 PULMONARY HYPERTENSION 16 0.0008
935 RHABDOMYOLYSIS 32 0.0008
936 EYE PAIN 43 0.0008
937 RESPIRATORY ARREST 21 0.0008
938 COMA 36 0.0008
939 WOUND 21 0.0008
940 METABOLIC ACIDOSIS 24 0.0007
941 PRODUCT USE ISSUE 135 0.0007
942 OVERDOSE 153 0.0007
943 OESOPHAGEAL CARCINOMA 21 0.0007
944 HEPATIC CANCER 17 0.0007
945 IRRITABLE BOWEL SYNDROME 15 0.0007
946 AGGRESSION 35 0.0007
947 ECZEMA 36 0.0007
948 INJURY 47 0.0007
949 KNEE ARTHROPLASTY 14 0.0007
950 TYPE 2 DIABETES MELLITUS 22 0.0007
951 THERAPEUTIC PRODUCT EFFECT DECREASED 29 0.0006
952 EYE SWELLING 24 0.0006
953 WHEEZING 38 0.0006
954 C-REACTIVE PROTEIN INCREASED 23 0.0006
955 MUCOSAL INFLAMMATION 16 0.0006
956 CRYING 22 0.0006
957 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
958 BONE DENSITY DECREASED 18 0.0006
959 EYE IRRITATION 31 0.0005
960 PRODUCT DOSE OMISSION ISSUE 156 0.0005
961 CHRONIC KIDNEY DISEASE 40 0.0005
962 LACTIC ACIDOSIS 17 0.0005
963 TOXICITY TO VARIOUS AGENTS 88 0.0005
964 OSTEONECROSIS 17 0.0005
965 THERAPEUTIC RESPONSE DECREASED 31 0.0005
966 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 13 0.0005
967 DRUG EFFECT DECREASED 27 0.0005
968 LOWER RESPIRATORY TRACT INFECTION 22 0.0005
969 INJECTION SITE PAIN 146 0.0005
970 SUICIDAL IDEATION 42 0.0005
971 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
972 SUICIDE ATTEMPT 25 0.0004
973 ANAPHYLACTIC REACTION 21 0.0004
974 MIGRAINE 36 0.0004
975 EXTRA DOSE ADMINISTERED 15 0.0004
976 DEVICE LEAKAGE 15 0.0003
977 DISEASE RECURRENCE 16 0.0003
978 SKIN BURNING SENSATION 22 0.0003
979 MEDICATION ERROR 17 0.0003
980 SKIN IRRITATION 14 0.0003
981 ACNE 23 0.0003
982 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
983 NO ADVERSE EVENT 50 0.0003
984 INJECTION SITE SWELLING 21 0.0003
985 ASTHMA 30 0.0003
986 PRODUCT QUALITY ISSUE 35 0.0003
987 PSORIASIS 32 0.0002
988 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
989 EMOTIONAL DISTRESS 23 0.0002
990 INJECTION SITE HAEMORRHAGE 14 0.0002
991 INJECTION SITE ERYTHEMA 20 0.0002
992 RHEUMATOID ARTHRITIS 16 0.0001